Nutritional and intestinal effects of the novel immunosuppressive agents: Deoxyspergualin, rapamycin, and mycophenolate mofetil

被引:16
作者
Yanchar, NL
Fedorak, RN
Kneteman, NM
Sigalet, DL
机构
[1] UNIV ALBERTA,DEPT SURG,DIV GEN SURG,MACKENZIE HLTH SCI CTR 2D437,EDMONTON,AB T6G 2B7,CANADA
[2] UNIV ALBERTA,DEPT MED,DIV GASTROENTEROL,MACKENZIE HLTH SCI CTR 2D437,EDMONTON,AB T6G 2B7,CANADA
关键词
intestinal permeability; glucose flux; nutrient absorption; morphology; rapamycin; deoxyspergualin; mycophenolate mofetil;
D O I
10.1016/0009-9120(96)00015-X
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Transplantation of the small intestine would be an attractive therapeutic option for treatment of short bowel syndrome if effective, nontoxic immunosuppressive agents could be developed. This study examines the effect of three newly developed immunosuppressive agents: rapamycin, deoxyspergualin, and mycophenolate mofetil, on the nutritional status and intestinal function of normal juvenile rats. Design & Methods: Rapamycin (2 mg/kg every second day), deoxyspergualin (2 mg/kg every second day) and mycophenolate mofetil (MM) (25 mg/kg every second day) were injected subcutaneously for six weeks. Results: Rapamycin and deoxyspergualin caused significant reductions in weight gain without impairing feed intake. Both drugs caused small decreases in fat absorption; treatment with DSG induced an increase in permeability to Tc-99-DTPA. However, the permeability to other markers, such as mannitol and lactulose, was decreased in the rapamycin and mycophenolate mofetil-treated animals. Intestinal function in vitro was quantified using glucose flux (absorption). In the rapamycin group, there was a significant decrease in ileal uptake of glucose, with the net flux (absorption) being zero; there was an associated loss of villous size histologically. In the deoxyspergualin-treated groups, there was a decrease in the jejunal glucose flux. In the mycophenolate mofetil-treated animals, there was a decrease in jejunal with a compensatory increase in ileal glucose absorption. There were minor variations in intestinal morphology, but these were not consistent. Conclusions: Rapamycin and deoxyspergualin in these doses cause a significant reduction in weight gain in healthy juvenile animals, and all the drugs caused changes in the active transport characteristics of the intestine. Accordingly, the use of these drugs for intestinal transplantation should be evaluated carefully for their nutritional impact.
引用
收藏
页码:363 / 369
页数:7
相关论文
共 38 条
[1]   IMMUNOSUPPRESSIVE AND OTHER EFFECTS OF MYCOPHENOLIC-ACID AND AN ESTER PRODRUG, MYCOPHENOLATE MOFETIL [J].
ALLISON, AC ;
EUGUI, EM .
IMMUNOLOGICAL REVIEWS, 1993, 136 :5-28
[2]  
*ASS OFF AN CHEM, 1986, METH AN
[3]  
BUMGARDNER GL, 1993, GASTROENTEROL CLIN N, V22, P421
[4]  
CALNE RY, 1989, LANCET, V2, P227
[5]  
CHEN H, 1992, TRANSPLANT P, V24, P1157
[6]   RAPAMYCIN FKBP SPECIFICALLY BLOCKS GROWTH-DEPENDENT ACTIVATION OF AND SIGNALING BY THE 70 KD S6 PROTEIN-KINASES [J].
CHUNG, J ;
KUO, CJ ;
CRABTREE, GR ;
BLENIS, J .
CELL, 1992, 69 (07) :1227-1236
[7]   SEGMENTAL SMALL INTESTINAL ALLOGRAFTS .2. INADEQUATE FUNCTION WITH CYCLOSPORINE IMMUNOSUPPRESSION - EVIDENCE OF A PROTEIN-LOSING ENTEROPATHY [J].
COLLIN, J ;
DENNISON, AR ;
WATKINS, RM ;
MILLARD, PR ;
MORRIS, PJ .
TRANSPLANTATION, 1987, 44 (04) :479-483
[8]   PROLONGATION OF CANINE INTESTINAL ALLOGRAFT SURVIVAL WITH RS-61443, CYCLOSPORINE, AND PREDNISONE [J].
DALESSANDRO, AM ;
RANKIN, M ;
MCVEY, J ;
HAFEZ, GR ;
SOLLINGER, HW ;
KALAYOGLU, M ;
BELZER, FO ;
STRATTA ;
AEDER ;
SHAFFER ;
NAJI .
TRANSPLANTATION, 1993, 55 (04) :695-701
[9]  
DEIERHOI MH, 1993, TRANSPLANT P, V25, P693
[10]  
DUMONT FJ, 1990, J IMMUNOL, V144, P1418